85 related articles for article (PubMed ID: 8388731)
1. Isolation of an endogenous Na-pump specific inhibitor from normal pig urine: characterization and comparison with the inhibitor purified from bovine adrenal glands.
Tamura M; Naruse M; Sakakibara M; Inagami T
Biochim Biophys Acta; 1993 May; 1157(1):15-22. PubMed ID: 8388731
[TBL] [Abstract][Full Text] [Related]
2. A novel endogenous sodium-pump inhibitor in pig urine: purification and comparison with the inhibitor purified from bovine adrenal glands.
Tamura M; Konishi F; Inagami T
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S47-50. PubMed ID: 7508027
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
Tamura M; Harris TM; Konishi F; Inagami T
Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
Tamura M; Lam TT; Inagami T
Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
[TBL] [Abstract][Full Text] [Related]
5. A Na pump inhibitor from bovine posterior pituitary: purification, structure determination and its cardiovascular effect in rat.
Hamakubo T; Furuta H; Ichimura M; Appalsamy M; Mosqueda-Garcia R; Robertson D; Inagami T
Biochem Biophys Res Commun; 1992 Dec; 189(2):691-6. PubMed ID: 1335244
[TBL] [Abstract][Full Text] [Related]
6. Identification of two cardiac glycosides as Na(+)-pump inhibitors in rat urine and diet.
Tamura M; Harris TM; Phillips D; Blair IA; Wang YF; Hellerqvist CG; Lam SK; Inagami T
J Biol Chem; 1994 Apr; 269(16):11972-9. PubMed ID: 8163500
[TBL] [Abstract][Full Text] [Related]
7. Specific endogenous Na, K-ATPase inhibitor purified from bovine adrenal.
Tamura M; Lam TT; Inagami T
Biochem Biophys Res Commun; 1987 Dec; 149(2):468-74. PubMed ID: 2827643
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of specific endogenous ouabainlike substance from bovine adrenal.
Inagami T; Tamura M
Am J Med Sci; 1988 Apr; 295(4):400-5. PubMed ID: 2834953
[TBL] [Abstract][Full Text] [Related]
9. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of a ouabain-like factor from Milan hypertensive rats.
Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036
[TBL] [Abstract][Full Text] [Related]
11. Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump.
Schneider R; Wray V; Nimtz M; Lehmann WD; Kirch U; Antolovic R; Schoner W
J Biol Chem; 1998 Jan; 273(2):784-92. PubMed ID: 9422732
[TBL] [Abstract][Full Text] [Related]
12. Purification and properties of endogenous ouabain-like substances from hemofiltrate and adrenal glands.
Schoner W; Heidrich-Lorsbach E; Kirch U; Ahlemeyer B; Sich B
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S29-31. PubMed ID: 7508021
[TBL] [Abstract][Full Text] [Related]
13. Identification of Na+,K+-ATPase inhibitors of volume-expanded hog plasma.
Inagami T; Tamura M
Hypertension; 1987 Nov; 10(5 Pt 2):I108-12. PubMed ID: 2824359
[TBL] [Abstract][Full Text] [Related]
14. Identification of Na+/K+-ATPase inhibitors in bovine plasma as fatty acids and hydrocarbons.
Tal DM; Yanuck MD; van Hall G; Karlish SJ
Biochim Biophys Acta; 1989 Oct; 985(1):55-9. PubMed ID: 2551389
[TBL] [Abstract][Full Text] [Related]
15. Ouabainlike factor in Milan hypertensive rats.
Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
[TBL] [Abstract][Full Text] [Related]
16. Endogenous "ouabain-like" activity in bovine plasma.
Tal DM; Katchalsky S; Lichtstein D; Karlish SJ
Biochem Biophys Res Commun; 1986 Feb; 135(1):1-8. PubMed ID: 3006675
[TBL] [Abstract][Full Text] [Related]
17. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis.
Zhao N; Lo LC; Berova N; Nakanishi K; Tymiak AA; Ludens JH; Haupert GT
Biochemistry; 1995 Aug; 34(31):9893-6. PubMed ID: 7632688
[TBL] [Abstract][Full Text] [Related]
18. Differential properties between an endogenous brain Na+, K(+)-ATPase inhibitor and ouabain.
Peña C; Rodríguez de Lores Arnaiz G
Neurochem Res; 1997 Apr; 22(4):379-83. PubMed ID: 9130247
[TBL] [Abstract][Full Text] [Related]
19. Ascorbic acid: an endogenous inhibitor of isolated Na+,K+-ATPase.
Ng YC; Akera T; Han CS; Braselton WE; Kennedy RH; Temma K; Brody TM; Sato PH
Biochem Pharmacol; 1985 Jul; 34(14):2525-30. PubMed ID: 2990490
[TBL] [Abstract][Full Text] [Related]
20. Purification of a Na+/K+ ATPase inhibitor from borderline hypertensives' plasma.
Boschi S; Borghi C; Munarini A; Costa FV; Lu ZR; deVries D; Ambrosioni E
Biochem Biophys Res Commun; 1990 Jun; 169(2):360-8. PubMed ID: 2162662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
